Altimmune to Present at Upcoming Investor and Scientific Conferences
GAITHERSBURG, Md., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will be presenting virtually at the following conferences:
Presentation materials, including webcast links to the Piper Sandle and Evercore ISI presentations, will be accessible on the Events section of the Altimmune website.
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (pemvidutide), and chronic hepatitis B (HepTcell™). For more information, please visit www.altimmune.com.
Altimmune Investor & Media Contact:
Keynote Presentation - Open to all Badge Holders
Killer Video Surveillance Solutions Across the Entire Cannabis Supply Chain
Keynote Panel Session - Open to all Badge Holders